These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3988241)

  • 41. The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3'-and 3'-5'-diiodothyronine and 3'-monoiodothyronine.
    Jaedig S; Faber J
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):388-92. PubMed ID: 7113605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monoiodothyronine (T1), diiodothyronine (T2)].
    Takeshita A
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():290-4. PubMed ID: 20960784
    [No Abstract]   [Full Text] [Related]  

  • 43. L--3',5'--diiodothyronine in human serum.
    Kirkegaard C; Faber J; Friis T; Lumholtz IB; Sierbaek-Nielsen K
    Lancet; 1978 Dec; 2(8102):1255. PubMed ID: 82760
    [No Abstract]   [Full Text] [Related]  

  • 44. Proceedings. Urinary cyclic AMP excretion in thyroid disease.
    Carter DJ; Heath DA
    Clin Sci Mol Med; 1974 Nov; 47(5):19P-20P. PubMed ID: 4373200
    [No Abstract]   [Full Text] [Related]  

  • 45. [Monoiodothyronine and diiodothyronine].
    Takeshita A
    Nihon Rinsho; 1999 Dec; 57 Suppl():86-9. PubMed ID: 10778070
    [No Abstract]   [Full Text] [Related]  

  • 46. A radioimmunoassay for 3,5-diiodothyronine.
    Meinhold H; Schürnbrand P
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):493-7. PubMed ID: 668156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary excretion of sulfate and glucuronate conjugates in a free living population of adult males.
    Murano PS; Robichaud VY; Webb RE
    Bull Environ Contam Toxicol; 1989 Jul; 43(1):13-6. PubMed ID: 2758129
    [No Abstract]   [Full Text] [Related]  

  • 48. 3'-L-Monoiodothyronine: development of a radioimmunoassay and demonstration of in vivo conversion from 3',5'-diiodothyronine.
    Smallridge RC; Wartofsky L; Green BJ; Miller FC; Burman KD
    J Clin Endocrinol Metab; 1979 Jan; 48(1):32-6. PubMed ID: 422702
    [No Abstract]   [Full Text] [Related]  

  • 49. 3,5-Diiodotyrosine and thyronine in the urine of patients with chronic renal disease.
    Ramsden DB; Farmer M; Mohammed MN; McGonigle RS; Sheppard MC
    Clin Endocrinol (Oxf); 1986 May; 24(5):491-5. PubMed ID: 3098453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Automated high-performance liquid chromatographic method for the determination of iodotyrosines and iodothyronines.
    Koostra PR; van den Broek HH; Hogendoorn EA; Goewie CE; de Vijlder JJ
    J Chromatogr; 1988 Dec; 458():175-83. PubMed ID: 3235633
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proceedings: Steroid metabolism in patients with thyroid diseases. (3). Conjugated cortisol-4-C 14 metabolite excretion patterns].
    Noto Y; Miyamoto M; Saito Y; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):418. PubMed ID: 4476489
    [No Abstract]   [Full Text] [Related]  

  • 52. Urinary phenolics and glucuronides in hexachlorocyclohexane isomers fed rats.
    Srinivasan K; Radhakrishnamurty R
    J Environ Sci Health B; 1989 Feb; 24(1):87-95. PubMed ID: 2468705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Excretion and conjugation pattern of urinary 17-ketosteroids in normal Indians.
    Singh RK; Bindal MC; Arora SR; Udupa KN
    Indian J Med Res; 1976 Mar; 64(3):430-4. PubMed ID: 965046
    [No Abstract]   [Full Text] [Related]  

  • 54. [Coefficient of the ratio of urine oxyproline to creatinine in children with thyroid gland pathology].
    Zaprudskaia DS; Ostashevskaia MI
    Pediatriia; 1973 Oct; 52(10):58. PubMed ID: 4783533
    [No Abstract]   [Full Text] [Related]  

  • 55. [Characterization of mono-iodohistidine and of diiodothyronine in labelled thyroglobulin].
    ROCHE J; LISSITZKY S; MICHEL R
    C R Hebd Seances Acad Sci; 1951 May; 232(22):2047-9. PubMed ID: 14849025
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the relations between the thyroid and the adrena cortex. 2. Behavior of urinary aldosterone in subjects with hyper- and hypothyroidism].
    DISPENSA E; DE LUCA F
    Rass Fisiopatol Clin Ter; 1961 Jul; 33():541-50. PubMed ID: 13886578
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolic activity of 3, 3'-diiodothyronine and 3, 3'-diiodo-5-bromothyronine.
    GEMMILL CL
    Am J Physiol; 1956 Jul; 186(1):1-5. PubMed ID: 13354740
    [No Abstract]   [Full Text] [Related]  

  • 58. [Measurement of triiodothyronine in urine].
    Yoshida K; Sakurada T; Kaise N; Yamamoto M; Kaise K
    Nihon Naibunpi Gakkai Zasshi; 1977 Jul; 53(7):844-53. PubMed ID: 578793
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolic activity of 3,5-dibromothyronine, 3,5-diiodothyronine and 3,3'-diiodo-5-bromothyronine.
    GEMMILL CL
    Am J Physiol; 1960 Jul; 199():91-3. PubMed ID: 13827251
    [No Abstract]   [Full Text] [Related]  

  • 60. Changes in the excretion pattern of drugs during long term administration.
    Pollmann W; Bechtel WD
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():164-71. PubMed ID: 5316398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.